Ann: End-of-Treatment Milestone Met in Phase 2 PTSD Trial, page-2

Treatment complete. I take it that just means the dosing phase of the trial?
"Topline Data Anticipated to be Reported Late Third Quarter 2018".
So late September before the headline results are reported.
I'll mostly be paying attention to the Primary End Point. Even if sub category results are reported they may be indicative only and require more focused future trials.
Guess we have to wait for the results before we find out the next steps. Potential partners will likely also take a wait and see approach.